content: <HTML>
  <HEAD>
  <TITLE>sv8</TITLE>
  </HEAD>
  <BODY bgcolor="#FFFFFF">
  <!-- PAGEBREAK -->
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  <DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
  <DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>
  
  
  
  
  <DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>SECURITIES AND EXCHANGE COMMISSION</B>
  </DIV>
  
  <DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
  </DIV>
  
  <DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
  </DIV>
  
  
  <DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT<BR>
  under<BR>
  THE SECURITIES ACT OF 1933</B>
  </DIV>
  
  <DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>HAEMONETICS CORPORATION</B>
  </DIV>
  
  <DIV align="center" style="font-size: 10pt">(Exact name of issuer as specified in its charter)</DIV>
  
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="47%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="47%">&nbsp;</TD>
  </TR>
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD align="center" valign="top"><B>Massachusetts</B>
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top"><B>04-2882273</B></TD>
  </TR>
  <TR valign="bottom">
      <TD align="center" valign="top">(State of Incorporation)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">(IRS Employer Identification Number)</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>400 Wood Road, Braintree, Massachusetts 02184 (781)&nbsp;848-7100</B><BR>
  (Address and telephone number of Principal Executive Offices)</DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Haemonetics Corporation</B></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>2005 Long-Term Incentive Compensation Plan</B><BR>
  (Full Title of the Plan)</DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>James O&#146;Shaughnessy, General Counsel<BR>
  Haemonetics Corporation<BR>
  400 Wood Road<BR>
  Braintree, Massachusetts 02184<BR>
  (781)&nbsp;848-7100</B><BR>
  (Name, address and telephone number of agent for service)</DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt">Copy to:<BR>
  <B>Mary Ellen O&#146;Mara<BR>
  Nixon Peabody LLP<BR>
  100 Summer Street<BR>
  Boston, Massachusetts 02110</B></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>
  
  <DIV style="font-size: 10pt; margin-top: 6pt">Indicate by check mark whether the registrant is a large
   accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
   of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting
   company&#148; in Rule&nbsp;12b-2 of the
   Exchange Act. (Check one):</DIV>
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom" style="font-size:6pt">
      <TD width="22%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="22%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
  <TD width="22%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="22%">&nbsp;</TD>
  </TR>
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD valign="top">Large accelerated filer <FONT face="Wingdings">&#254;</FONT></TD>   <TD>&nbsp;</TD>
      <TD align="center" valign="top">Accelerated filer
  <FONT face="Wingdings">&#111;</FONT></TD><TD>&nbsp;</TD>
      <TD align="center" valign="top">Non-accelerated filer <FONT face="Wingdings">&#111;</FONT></TD><TD>&nbsp;</TD>
      <TD align="right" valign="top">Smaller reporting company <FONT face="Wingdings">&#111;</FONT></TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top" nowrap>(Do not check if a smaller reporting company)</TD>
      <TD>&nbsp;</TD>
  <TD align="right" valign="top">&nbsp;</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>CALCULATION OF REGISTRATION FEE</B>
  </DIV>
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="1%">&nbsp;</TD>
      <TD width="42%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="11%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="7%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="19%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="11%">&nbsp;</TD>
  
      <TD width="1%">&nbsp;</TD>
  </TR><TR style="font-size: 1px" valign="bottom">
      <TD nowrap align="left" colspan="15" style="border-bottom: 3px double #000000">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Proposed Maximum</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Proposed Maximum</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>Title of Securities</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Amount to Be</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Offering Price</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Aggregate</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Amount of</B></TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>to be Registered</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Registered(1)</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Per Share</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Offering Price</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Registration Fee</B></TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                      <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, $.01 par value
  Shares Not Previously
  Registered(2)</DIV></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="center" valign="bottom" style="border-top: 2px solid #000000">1,475,566</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$52.55</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="center" valign="bottom" style="border-top: 2px solid #000000">77,540,993.30</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
  
  <TD align="center" valign="bottom" style="border-top: 2px solid #000000">4,326.79</TD>
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$77,540,993.30</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
  
  <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$4,326.79</TD>
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
  </TR>
  <TR style="font-size: 1px" valign="bottom">
      <TD nowrap align="left" colspan="15" style="border-top: 3px double #000000">&nbsp;</TD>
  </TR>
  
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <DIV align="left">
  <DIV style="font-size: 3pt; margin-top: 3pt; width: 18%; border-top: 0px solid #000000">&nbsp;</DIV>
  </DIV>
  
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  <TR>
      <TD width="3%"></TD>
      <TD width="1%"></TD>
      <TD width="96"></TD>
  </TR>
  
  <TR valign="top">
      <TD nowrap align="left">(1)</TD>
      <TD>&nbsp;</TD>
      <TD>Also registered hereunder are such additional number of shares of Common Stock,
  presently indeterminable, as may be necessary to satisfy the anti-dilution provisions of the
  Plan to which this Registration Statement relates.</TD>
  </TR>
  
  <TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>
  
  <TR valign="top">
      <TD nowrap align="left">(2)</TD>
      <TD>&nbsp;</TD>
      <TD>The registration fee has been calculated with respect to 1,475,566 shares
  registered on the basis of the average price of $52.55 on the New York Stock Exchange on May
  19, 2009.</TD>
  </TR>
  
  </TABLE>
  
  
  
  <DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
  <DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
  
  
  
  
  
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  
  
  
  <!-- TOC -->
  <A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>
  
  <P><CENTER>
  <TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
  <TR>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="76%"></TD>
  </TR>
  <TR><TD colspan="9"><A HREF="#000">PART II</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;3 Incorporation of Documents by Reference</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;4 Description of Securities</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;5 Interests of Named Experts and Counsel</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#004">Item&nbsp;6 Indemnification of Directors and Officers</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#005">Item&nbsp;7 Exemption from Registration Claimed</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#006">Item&nbsp;8 Exhibits</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#007">Item&nbsp;9 Undertakings</A></TD></TR>
  <TR><TD colspan="9"><A HREF="#008">SIGNATURES</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b75623hcexv4wa.htm">Ex-4A Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b75623hcexv5.htm">Ex- 5 Opinion of James O'Shaughnessy, General Counsel of Haemonetics Corporation, as to legality of shares being registered and consent</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b75623hcexv23.htm">Ex-23 Consents of Experts - included in Registration Statement under heading "Consent of Independent Public Accountants."</A></TD></TR>
  </TABLE>
  </CENTER>
  <!-- /TOC -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  
  
  
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Registration Statement is being filed solely for the purpose of registering 1,475,566
  additional shares of common stock of Haemonetics Corporation issuable pursuant to the 2005 Long
  Term Incentive Compensation Plan (the &#147;2005 Plan&#148;). A total of 3,100,000 shares of common stock were previously
  registered on Form S-8 (Registration No.&nbsp;333-136839).
   Pursuant to Instruction E to Form S-8, the
  contents of the Registration Statement on Form S-8 (Registration No.&nbsp;333-136839) are herein
  incorporated by reference.
  </DIV>
  
  <!-- link1 "PART II" -->
  <DIV align="left"><A NAME="000"></A></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt">PART II
  </DIV>
  
  
  <DIV align="Center" style="font-size: 10pt; margin-top: 6pt">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  
  </DIV>
  <!-- link2 "Item&nbsp;3 Incorporation of Documents by Reference" -->
  <DIV align="left"><A NAME="001"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Item&nbsp;3</U>. <U>Incorporation of Documents by Reference</U>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby incorporates by reference the documents listed in (a)&nbsp;through (c)&nbsp;below.
  In addition, all documents subsequently filed by the Company pursuant to Section&nbsp;13(a), 13(c), 14
  and 15(d) of the Securities Exchange Act of 1934 (prior to the filing of a Post-Effective Amendment
  which indicates that all securities offered have been sold or which deregisters all securities then
  remaining unsold) shall be deemed to be incorporated by reference in this Registration Statement
  and to be a part thereof from the date of filing of such documents. Any statement contained herein
  or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to
  be modified or superseded for purposes of this Registration Statement to the extent that a
  statement contained herein or in any other subsequently filed document which also is incorporated
  or is deemed to be incorporated by reference herein modifies or supersedes such earlier statement.
  Any statement so modified or superseded shall not be deemed, except as so modified or superseded,
  to constitute part of this Registration Statement.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company&#146;s latest annual report filed pursuant to Section 13(a) or 15(d)
  of the Securities Exchange Act of 1934 or the latest Prospectus filed pursuant to Rule 424(b) under
  the Securities Act of 1933, which contains either directly or by incorporation by reference audited
  financial statements for the Company&#146;s latest fiscal year for which such statements have been
  filed.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All other reports filed pursuant to Section 13(a) or 15(d) of the Securities
  Exchange Act of 1934 since the end of the fiscal year covered by the annual report or the
  Prospectus referred to in (a)&nbsp;above.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The description of the Company&#146;s Common Stock which is contained in the
  Registration Statement filed by the Company under the Securities Exchange Act of 1934, including
  any amendment or report filed for the purpose of updating such description.
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  <!-- link2 "Item&nbsp;4 Description of Securities" -->
  <DIV align="left"><A NAME="002"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Item&nbsp;4</U>. <U>Description of Securities</U>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inapplicable.
  </DIV>
  <!-- link2 "Item&nbsp;5 Interests of Named Experts and Counsel" -->
  <DIV align="left"><A NAME="003"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Item&nbsp;5</U>. <U>Interests of Named Experts and Counsel</U>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the authorization and issuance of the Common Stock offered hereby will be
  passed upon for the Company by James O&#146;Shaughnessy, General Counsel of Haemonetics Corporation.
  Mr.&nbsp;O&#146;Shaughnessy holds options to purchase Common Stock, Restricted Stock Units and owns shares of
  Common Stock.
  </DIV>
  <!-- link2 "Item&nbsp;6 Indemnification of Directors and Officers" -->
  <DIV align="left"><A NAME="004"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Item&nbsp;6</U>. <U>Indemnification of Directors and Officers</U>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated by reference to Registration Statement on Form S-8 (Registration No.&nbsp;333-136839)
  </DIV>
  <!-- link2 "Item&nbsp;7 Exemption from Registration Claimed" -->
  <DIV align="left"><A NAME="005"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Item&nbsp;7</U>. <U>Exemption from Registration Claimed</U>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inapplicable.
  </DIV>
  <!-- link2 "Item&nbsp;8 Exhibits" -->
  <DIV align="left"><A NAME="006"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Item&nbsp;8</U>. <U>Exhibits</U>
  </DIV>
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="4%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="93%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">
      <TD nowrap align="center" style="border-bottom: 1px solid #000000">Number</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
  </TR>
  <TR valign="bottom">
      <TD width="4%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="93%">&nbsp;</TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4A
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">5
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Opinion of James O&#146;Shaughnessy, General Counsel of Haemonetics
  Corporation, as to legality of shares being registered and consent.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consents of Experts&#151;included in Registration Statement under
  heading &#147;Consent of Independent Public Accountants.&#148;</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  <!-- link2 "Item&nbsp;9 Undertakings" -->
  <DIV align="left"><A NAME="007"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Item&nbsp;9</U>. <U>Undertakings</U>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Registrant hereby undertakes the following:
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The undersigned Registrant hereby undertakes:
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;To file, during any period in which offers or sales are being made, a post-effective
  amendment to this registration statement:
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933;
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;To reflect in the prospectus any facts or events arising after the effective date of the
  registration statement (or the most recent post-effective amendment thereof) which, individually or
  in the aggregate, represent a fundamental change in the information set forth in the registration
  statement;
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;To include any material information with respect to the plan of distribution not
  previously disclosed in the registration statement or any material change to such information in
  the registration statement.
  </DIV>
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information
  required to be included in a post-effective amendment by those paragraphs is contained in periodic
  reports filed with or furnished to the Commission by the registrant pursuant to Section&nbsp;13 or
  Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the
  registration statement.
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;That, for the purpose of determining any liability under the Securities Act
  of 1933, each such post-effective amendment shall be deemed to be a new registration statement
  relating to the securities offered therein, and the offering of such securities at that time shall
  be deemed to be the initial bona fide offering thereof.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;To remove from registration by means of a post-effective amendment any of
  the securities being registered which remain unsold at the termination of the offering.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The undersigned registrant hereby undertakes that, for purposes of determining any
  liability under the Securities Act of 1933, each filing of the registrant&#146;s annual report pursuant
  to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
  each filing of an employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Securities
  Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
  deemed to be a new registration statement relating to the securities offered
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">therein, and the offering of such securities at that time shall be deemed to be the initial bona
  fide offering thereof.
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The undersigned registrant hereby undertakes, that, insofar as indemnification for
  liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and
  controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the
  registrant has been advised that in the opinion of the Securities and Exchange Commission such
  indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.
  In the event that a claim for indemnification against such liabilities (other than the payment by
  the registrant of expenses incurred or paid by a director, officer or controlling person of the
  registrant in the successful defense of any action, suit or proceeding) is asserted by such
  director, officer or controlling person in connection with the securities being registered, the
  registrant will, unless in the opinion of its counsel the matter has been settled by controlling
  precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
  by it is against public policy as expressed in the Act and will be governed by the final
  adjudication of such issue.
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  <!-- link1 "SIGNATURES" -->
  <DIV align="left"><A NAME="008"></A></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt">SIGNATURES
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
  has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
  has duly caused this Registration Statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in Braintree, Massachusetts on May&nbsp;22, 2009.
  </DIV>
  
  
  <TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
  <TR>
      <TD width="48%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="35%">&nbsp;</TD>
      <TD width="15%">&nbsp;</TD>
  </TR>
  <TR>
      <TD valign="top" align="left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD colspan="2" align="left">HAEMONETICS CORPORATION<BR>
  &nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD valign="top">By:&nbsp;&nbsp;</TD>
      <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Brian Concannon
  &nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD colspan="2" align="left">Brian Concannon&nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR>
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  </TABLE>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt">POWER OF ATTORNEY
  </DIV>
  
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL MEN BY THESE PRESENTS that each person whose signature appears below constitutes and
  appoints Brian Concannon his/her true and lawful attorneys-in-fact and agents, each acting alone,
  with full powers of substitution and resubstitution, for him/her or in his/her name, place and
  stead, in any and all capacities to sign any and all amendments or post-effective amendments to
  this Registration Statement (or any registration statement for the same offering that is to be
  effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the
  same, with all exhibits thereto, and other documents in connection therewith, with the Securities
  and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full
  power and authority to do any perform each and every act and thing requisite or necessary to be
  done in and about the premises, as fully to all intents and purposes as he/she might or could do in
  person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting
  alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has
  been signed by the following persons in the capacities and on the dates indicated.
  </DIV>
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="35%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="4%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="45%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="10%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">
      <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Signature</B></TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Brian Concannon
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Brian Concannon
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><BR STYLE="FONT-SIZE: 6PT">President and Chief Executive Officer<br>
  (Principal Executive Officer)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Christopher Lindop
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Christopher Lindop
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><BR STYLE="FONT-SIZE: 6PT">Chief Financial Officer and Vice
  President Business Development<br>
  (Principal Financial Officer)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Susan M. Hanlon
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Susan M. Hanlon
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><BR STYLE="FONT-SIZE: 6PT">Vice President Finance<br>
  (Principal Accounting Officer)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Brad Nutter
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Brad Nutter
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">Executive Chairman of the Board
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Lawrence C. Best
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Lawrence C. Best
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Susan B. Foote
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Susan B. Foote
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Ronald G. Gelbman
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Ronald G. Gelbman
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Pedro P. Granadillo
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Pedro P. Granadillo
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Mark W. Kroll
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Mark W. Kroll
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Ronald L. Merriman
  <DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
  Ronald L. Merriman
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">&nbsp;
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="bottom">Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top"><FONT style="white-space: nowrap">May&nbsp;22, 2009</FONT></TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
  </DIV>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "b75623hcsv8.htm", "description": "HAEMONETICS CORPORATION", "secsgml_size_bytes": 40914}]
metadata_filer: {"company-data": {"conformed-name": "HAEMONETICS CORP", "cik": "0000313143", "assigned-sic": "3841", "irs-number": "042882273", "state-of-incorporation": "MA", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-159434", "film-number": "09848486"}, "business-address": {"street1": "400 WOOD RD", "city": "BRAINTREE", "state": "MA", "zip": "02184", "phone": "7818487100"}, "mail-address": {"street1": "400 WOOD ROAD", "city": "BRAINTREE", "state": "MA", "zip": "02184"}}
text: sv8
  Table of Contents
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM S-8
  REGISTRATION STATEMENT
  under
  THE SECURITIES ACT OF 1933
  HAEMONETICS CORPORATION
  (Exact name of issuer as specified in its charter)
  Massachusetts
  04-2882273
  (State of Incorporation)
  (IRS Employer Identification Number)
  400 Wood Road, Braintree, Massachusetts 02184 (781) 848-7100
  (Address and telephone number of Principal Executive Offices)
  Haemonetics Corporation
  2005 Long-Term Incentive Compensation Plan
  (Full Title of the Plan)
  James O'Shaughnessy, General Counsel
  Haemonetics Corporation
  400 Wood Road
  Braintree, Massachusetts 02184
  (781) 848-7100
  (Name, address and telephone number of agent for service)
  Copy to:
  Mary Ellen O'Mara
  Nixon Peabody LLP
  100 Summer Street
  Boston, Massachusetts 02110
  Indicate by check mark whether the registrant is a large
   accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
   of "large accelerated filer," "accelerated filer" and "smaller reporting
   company" in Rule 12b-2 of the
   Exchange Act. (Check one):
  Large accelerated filer
  þ
  Accelerated filer
  o
  Non-accelerated filer
  o
  Smaller reporting company
  o
  (Do not check if a smaller reporting company)
  CALCULATION OF REGISTRATION FEE
  Proposed Maximum
  Proposed Maximum
  Title of Securities
  Amount to Be
  Offering Price
  Aggregate
  Amount of
  to be Registered
  Registered(1)
  Per Share
  Offering Price
  Registration Fee
  Common Stock, $.01 par value
  Shares Not Previously
  Registered(2)
  1,475,566
  $52.55
  77,540,993.30
  4,326.79
  Total
  $77,540,993.30
  $4,326.79
  (1)
  Also registered hereunder are such additional number of shares of Common Stock,
  presently indeterminable, as may be necessary to satisfy the anti-dilution provisions of the
  Plan to which this Registration Statement relates.
  (2)
  The registration fee has been calculated with respect to 1,475,566 shares
  registered on the basis of the average price of $52.55 on the New York Stock Exchange on May
  19, 2009.
  TABLE OF CONTENTS
  PART II
  Item 3 Incorporation of Documents by Reference
  Item 4 Description of Securities
  Item 5 Interests of Named Experts and Counsel
  Item 6 Indemnification of Directors and Officers
  Item 7 Exemption from Registration Claimed
  Item 8 Exhibits
  Item 9 Undertakings
  SIGNATURES
  Ex-4A Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan
  Ex- 5 Opinion of James O'Shaughnessy, General Counsel of Haemonetics Corporation, as to legality of shares being registered and consent
  Ex-23 Consents of Experts - included in Registration Statement under heading "Consent of Independent Public Accountants."
  Table of Contents
  This Registration Statement is being filed solely for the purpose of registering 1,475,566
  additional shares of common stock of Haemonetics Corporation issuable pursuant to the 2005 Long
  Term Incentive Compensation Plan (the "2005 Plan"). A total of 3,100,000 shares of common stock were previously
  registered on Form S-8 (Registration No. 333-136839).
   Pursuant to Instruction E to Form S-8, the
  contents of the Registration Statement on Form S-8 (Registration No. 333-136839) are herein
  incorporated by reference.
  PART II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item 3
  .
  Incorporation of Documents by Reference
  The Company hereby incorporates by reference the documents listed in (a) through (c) below.
  In addition, all documents subsequently filed by the Company pursuant to Section 13(a), 13(c), 14
  and 15(d) of the Securities Exchange Act of 1934 (prior to the filing of a Post-Effective Amendment
  which indicates that all securities offered have been sold or which deregisters all securities then
  remaining unsold) shall be deemed to be incorporated by reference in this Registration Statement
  and to be a part thereof from the date of filing of such documents. Any statement contained herein
  or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to
  be modified or superseded for purposes of this Registration Statement to the extent that a
  statement contained herein or in any other subsequently filed document which also is incorporated
  or is deemed to be incorporated by reference herein modifies or supersedes such earlier statement.
  Any statement so modified or superseded shall not be deemed, except as so modified or superseded,
  to constitute part of this Registration Statement.
  (a) The Company's latest annual report filed pursuant to Section 13(a) or 15(d)
  of the Securities Exchange Act of 1934 or the latest Prospectus filed pursuant to Rule 424(b) under
  the Securities Act of 1933, which contains either directly or by incorporation by reference audited
  financial statements for the Company's latest fiscal year for which such statements have been
  filed.
  (b) All other reports filed pursuant to Section 13(a) or 15(d) of the Securities
  Exchange Act of 1934 since the end of the fiscal year covered by the annual report or the
  Prospectus referred to in (a) above.
  (c) The description of the Company's Common Stock which is contained in the
  Registration Statement filed by the Company under the Securities Exchange Act of 1934, including
  any amendment or report filed for the purpose of updating such description.
  2
  Table of Contents
  Item 4
  .
  Description of Securities
  Inapplicable.
  Item 5
  .
  Interests of Named Experts and Counsel
  The validity of the authorization and issuance of the Common Stock offered hereby will be
  passed upon for the Company by James O'Shaughnessy, General Counsel of Haemonetics Corporation.
  Mr. O'Shaughnessy holds options to purchase Common Stock, Restricted Stock Units and owns shares of
  Common Stock.
  Item 6
  .
  Indemnification of Directors and Officers
  Incorporated by reference to Registration Statement on Form S-8 (Registration No. 333-136839)
  Item 7
  .
  Exemption from Registration Claimed
  Inapplicable.
  Item 8
  .
  Exhibits
  Number
  Description
  4A
  Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan.
  5
  Opinion of James O'Shaughnessy, General Counsel of Haemonetics
  Corporation, as to legality of shares being registered and consent.
  23
  Consents of Experts—included in Registration Statement under
  heading "Consent of Independent Public Accountants."
  Item 9
  .
  Undertakings
  The undersigned Registrant hereby undertakes the following:
  (a) The undersigned Registrant hereby undertakes:
  3
  Table of Contents
  (1) To file, during any period in which offers or sales are being made, a post-effective
  amendment to this registration statement:
  (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
  (ii) To reflect in the prospectus any facts or events arising after the effective date of the
  registration statement (or the most recent post-effective amendment thereof) which, individually or
  in the aggregate, represent a fundamental change in the information set forth in the registration
  statement;
  (iii) To include any material information with respect to the plan of distribution not
  previously disclosed in the registration statement or any material change to such information in
  the registration statement.
  Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information
  required to be included in a post-effective amendment by those paragraphs is contained in periodic
  reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or
  Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the
  registration statement.
  (2) That, for the purpose of determining any liability under the Securities Act
  of 1933, each such post-effective amendment shall be deemed to be a new registration statement
  relating to the securities offered therein, and the offering of such securities at that time shall
  be deemed to be the initial bona fide offering thereof.
  (3) To remove from registration by means of a post-effective amendment any of
  the securities being registered which remain unsold at the termination of the offering.
  (b) The undersigned registrant hereby undertakes that, for purposes of determining any
  liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant
  to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
  each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities
  Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
  deemed to be a new registration statement relating to the securities offered
  4
  Table of Contents
  therein, and the offering of such securities at that time shall be deemed to be the initial bona
  fide offering thereof.
  (c) The undersigned registrant hereby undertakes, that, insofar as indemnification for
  liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and
  controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the
  registrant has been advised that in the opinion of the Securities and Exchange Commission such
  indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.
  In the event that a claim for indemnification against such liabilities (other than the payment by
  the registrant of expenses incurred or paid by a director, officer or controlling person of the
  registrant in the successful defense of any action, suit or proceeding) is asserted by such
  director, officer or controlling person in connection with the securities being registered, the
  registrant will, unless in the opinion of its counsel the matter has been settled by controlling
  precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
  by it is against public policy as expressed in the Act and will be governed by the final
  adjudication of such issue.
  5
  Table of Contents
  SIGNATURES
  Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
  has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
  has duly caused this Registration Statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in Braintree, Massachusetts on May 22, 2009.
  HAEMONETICS CORPORATION
  By:
  /s/ Brian Concannon
  Brian Concannon
  President and Chief Executive Officer
  POWER OF ATTORNEY
  KNOW ALL MEN BY THESE PRESENTS that each person whose signature appears below constitutes and
  appoints Brian Concannon his/her true and lawful attorneys-in-fact and agents, each acting alone,
  with full powers of substitution and resubstitution, for him/her or in his/her name, place and
  stead, in any and all capacities to sign any and all amendments or post-effective amendments to
  this Registration Statement (or any registration statement for the same offering that is to be
  effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the
  same, with all exhibits thereto, and other documents in connection therewith, with the Securities
  and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full
  power and authority to do any perform each and every act and thing requisite or necessary to be
  done in and about the premises, as fully to all intents and purposes as he/she might or could do in
  person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting
  alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
  6
  Table of Contents
  Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has
  been signed by the following persons in the capacities and on the dates indicated.
  Signature
  Title
  Date
  /s/ Brian Concannon
  Brian Concannon
  President and Chief Executive Officer
  (Principal Executive Officer)
  May 22, 2009
  /s/ Christopher Lindop
  Christopher Lindop
  Chief Financial Officer and Vice
  President Business Development
  (Principal Financial Officer)
  May 22, 2009
  /s/ Susan M. Hanlon
  Susan M. Hanlon
  Vice President Finance
  (Principal Accounting Officer)
  May 22, 2009
  /s/ Brad Nutter
  Brad Nutter
  Executive Chairman of the Board
  May 22, 2009
  /s/ Lawrence C. Best
  Lawrence C. Best
  Director
  May 22, 2009
  /s/ Susan B. Foote
  Susan B. Foote
  Director
  May 22, 2009
  /s/ Ronald G. Gelbman
  Ronald G. Gelbman
  Director
  May 22, 2009
  /s/ Pedro P. Granadillo
  Pedro P. Granadillo
  Director
  May 22, 2009
  /s/ Mark W. Kroll
  Mark W. Kroll
  Director
  May 22, 2009
  /s/ Ronald L. Merriman
  Ronald L. Merriman
  Director
  May 22, 2009
  7